Dr. Otavio Berwanger reflects on the BRIDGE-ACS trial, which evaluated whether a multifaceted quality improvement intervention can improve the use of evidence-based therapies and reduce the incidence of major cardiovascular events among patients with ACS in a middle-income country.  The findings were simultaneously published in JAMA.